Market Analysis 2019-2027 Antiviral Drug Resistance Market | страница 2

Global Antiviral Drug Resistance Market to 2027
www.theinsightpartners.com
The global antiviral drug resistance market expected to be US$ 2,572.26 Mn in 2018 and is
predicted to grow at a CAGR of 6.8% during the forecast period 2019 - 2027, to reach US$
4,573.24 Mn by 2027.
Europe is the second largest geographic market and is expected to be the second most
significant revenue contributor throughout the forecast period. The region has witnessed
several advancements in the field of biotechnology due to increased emphasis on R&D
activities in the region. The growth is driven by factors such as increased prevalence of HIV
and hepatitis and supportive policies by the government to tackle burden of the diseases.
Market Insights
Rise in the Incidences of Hepatitis Diseases
Viruses are the tinier germs that can cause several infectious diseases such as flu, common
cold, and warts. Viruses can also cause severe illnesses, including smallpox, HIV/AIDS, and
Ebola. Viruses reproduce inside cells and able to enter into any living, healthy cells and
multiply and produce other viruses like themselves. Different viruses attack specific cells in
the body such as liver, brain, skin, blood and also reproductive, respiratory, and
gastrointestinal systems.
The prevalence of virus infections such as hepatitis has increased during recent years across
the globe. Hepatitis causes liver damage and inflammation that can also damage other
organs. It is a major global health problem that can cause chronic infection and also upsurge
the higher risk of death from cirrhosis and liver cancer. Hepatitis can be categorized as
hepatitis A, B, C, D, and E that spread through different causes. According to the WHO (World
Health Organization), the prevalence of Hepatitis B is the highest in the African and Western
Pacific Region, where 6.1% and 6.2% of the adult population is infected respectively.
Increasing Healthcare Expenditures in Emerging Markets
The increasing healthcare expenditure in the emerging economies such as Asia Pacific and
South and Central America are enabling the researchers to develop treatment options for a
wide range of viral diseases by utilizing advanced techniques such as PCR (Polymerase Chain
2